RA Capital Management’s Icosavax, Inc. Common Stock ICVX Stock Holding History

RA Capital Management’s Portfolio ICVX Stock Details ICVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-5,963,565	Closed	-$94M	–	81
2023 Q4	$94M	Hold	5,963,565	–	–	1.47%	18
2023 Q3	$46.2M	Hold	5,963,565	–	–	0.91%	32
2023 Q2	$59.2M	Hold	5,963,565	–	–	1.12%	27
2023 Q1	$34.6M	Hold	5,963,565	–	–	0.78%	39
2022 Q4	$47.4M	Hold	5,963,565	–	–	0.96%	32
2022 Q3	$18.8M	Hold	5,963,565	–	–	0.4%	52
2022 Q2	$34.2M	Hold	5,963,565	–	–	0.91%	34
2022 Q1	$42M	Buy	5,963,565 +184,218	+3%	+$2.9M	0.92%	33
2021 Q4	$132M	Hold	5,779,347	–	–	2.33%	9
2021 Q3	$171M	Buy	+5,779,347	New	+$196M	2.37%	11

RA Capital Management's ICVX Position: Q1 2024 in Review

RA Capital Management sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 5,963,565 shares — an estimated $94M sold.

RA Capital Management first reported a position in ICVX in Q3 2021 and held it in 10 quarters. The position peaked at $171M in Q3 2021. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

RA Capital Management reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
RA Capital Management sold 5,963,565 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $94M.
RA Capital Management first reported a position in Icosavax, Inc. Common Stock in Q3 2021 and held it in 10 quarters.
RA Capital Management's Icosavax, Inc. Common Stock position peaked at $171M in Q3 2021.
0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on RA Capital Management's 13F filing for Q1 2024, filed 15 May 2024.